Terremoto Biosciences
PrivateLast Round
Series C
Apr 15, 2026
Total Funding Raised
$358M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Terremoto Biosciences operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series C round in April 2026.
Terremoto Biosciences is a biotechnology company that develops a drug discovery and development platform for highly targeted, small-molecule medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Terremoto Biosciences Comparables
Compare Terremoto Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alterome Therapeutics | 93% | |
| Atavistik | 84% | |
| Treeline Biosciences | 82% |
For institutional investors. Book with your work email.
Terremoto Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 15, 2026 | ||||
| Series B | Nov 2, 2023 | ||||
| Series A | May 25, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Terremoto Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series B |
| RA Capital Management | Series C |
| Cormorant Asset Management | Series C, Series B |
| Deep Track Capital | Series C |
| Osage University Partners | Series C |
| OrbiMed | Series C, Series B, Series A |
| Cormorant Capital | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 55% MoM, from 3.2K to 5K.
- Apr 15, 2026
$108M round completed.
For institutional investors. Book with your work email.
Terremoto Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Terremoto Biosciences's valuation, stock price, and market status.
Is Terremoto Biosciences a public or private company?
Terremoto Biosciences is a private company.
What is the current stock price of Terremoto Biosciences?
Terremoto Biosciences is a private company, so its shares have no public market price. Caplight tracks Terremoto Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Terremoto Biosciences worth (valuation)?
Valuation information for Terremoto Biosciences is not publicly available.
Can I buy Terremoto Biosciences stock?
Terremoto Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Terremoto Biosciences's last funding round?
Terremoto Biosciences's most recent funding round was Series C on April 15, 2026.
Who are the main investors in Terremoto Biosciences?
Key investors in Terremoto Biosciences include EcoR1 Capital, OrbiMed, Novo Holdings, Third Rock Ventures.
Will Terremoto Biosciences IPO soon?
No public IPO plans have been announced for Terremoto Biosciences.
How can I track Terremoto Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Terremoto Biosciences's shares on secondary markets.